TY  - RPRT
TI  - Genetic evidence supports the prioritization of CD40 among prespecified immune-related candidate drug targets in myasthenia gravis.
AU  - Yue Xu
AU  - Xiaolei Li
AU  - Guangxian Nan
PY  - 2026
DO  - 10.1080/00207454.2026.2733265
UR  - https://pubmed.ncbi.nlm.nih.gov/42727063/
ID  - 42727063
ER  -